IP Library Granted Patent US 10,428,214
Granted Patent B2
US 10,428,214 · App. 16/091,702 · Granted Oct 1, 2019

Cationically curable resin composition

Inventor: Hiroto Matsuoka (Tokyo, JP)
Assignee: THREEBOND CO., LTD.
C08L63/00C08G59/00C08G59/24C08K5/3477C08L2201/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,428,214
App. No.
16/091,702
Granted
Oct 1, 2019
Kind
B2
Abstract

The present invention addresses the problem of providing a cationically curable resin composition having storage stability while maintaining photocurability and low-temperature (less than 100° C.) curability. The cationically curable resin composition can include component (A): a cationically polymerizable compound, component (B): a photo-cationic polymerization initiator, component (C): a thermal cationic polymerization initiator, and component (D): a compound having an isocyanuric ring. Also, the content of the component (D) can be 0.01 to 7 parts by mass per 100 parts by mass of the component (A).

Claims (18)

1. A cationically curable resin composition comprising:

component (A): a cationically polymerizable compound;

component (B): a photo-cationic polymerization initiator;

component (C): a thermal cationic polymerization initiator; and

component (D): a compound having an isocyanuric ring,

wherein a content of the component (D) is 0.01 to 5 parts by mass per 100 parts by mass of the component (A).

2. The cationically curable resin composition according to claim 1 , wherein the component (D) is at least one member selected from the group consisting of a compound containing a (meth)acryloyl group and an isocyanuric ring, a compound containing an allyl group and an isocyanuric ring, a compound containing a glycidyl group and an isocyanuric ring, and a compound containing a mercapto group and an isocyanuric ring.

3. The cationically curable resin composition according to claim 1 , wherein the component (C) is an aromatic sulfonium-based thermal cationic polymerization initiator or an aromatic iodonium-based thermal cationic polymerization initiator.

4. The cationically curable resin composition according to claim 1 , further comprising:

component (E): a pigment.

5. The cationically curable resin composition according to claim 1 , wherein the component (A) is a hydrogenated epoxy resin or an alicyclic epoxy compound.

6. The cationically curable resin composition according to claim 1 , wherein the component (A) comprises a hydrogenated epoxy resin.

7. The cationically curable resin composition according to claim 1 , wherein an amount of the component (B) is 0.1 to 30 parts by mass per 100 parts by mass of the component (A).

8. The cationically curable resin composition according to claim 1 , wherein an amount of the component (C) is 0.1 to 30 parts by mass per 100 parts by mass of the component (A).

9. The cationically curable resin composition according to claim 1 , wherein the component (A) is at least one selected from a group consisting of a hydrogenated bisphenol A epoxy resin, a hydrogenated bisphenol F epoxy resin, a hydrogenated bisphenol E epoxy resin, a diglycidyl ether of an alkylene oxide adduct of a hydrogenated bisphenol A, a diglycidyl ether of an alkylene oxide adduct of a hydrogenated bisphenol F, a hydrogenated phenol novolac epoxy resin, and a hydrogenated cresol novolac epoxy resin.

10. The cationically curable resin composition according to claim 1 , wherein the cationically curable resin composition can be cured by active energy ray irradiation and a low temperature.

11. The cationically curable resin composition according to claim 1 , wherein the component (B) is at least one selected from a group consisting of triphenylsulfonium hexafluoroantimonate, triphenylsulfonium tetrakis(pentafluorophenyl)borate, 4,4′-bis[di(β-hydroxyethoxy)phenylsulfonio]diphenylsulfide-bishexafluoroantimonate, 7-[di(p-toluyl)sulfonio]-2-isopropylthioxanthone hexafluoroantimonate, 7-[di(p-toluyl)sulfonio]-2-isopropylthioxanthone tetrakis(pentafluorophenyl)borate, 4-(p-ter-butylphenylcarbonyl)-4′-diphenylsulfonio-diphenylsulfide-hexafluoroantimonate, 4-(p-ter-butylphenylcarbonyl)-4′-di(p-tolyl)sulfoniodiphenylsulfide-tetrakis(pentafluorophenyl)borate, diphenyliodonium tetrakis(pentafluorophenyl)borate, diphenyliodonium hexafluorophosphate, diphenyliodonium hexafluoroantimonate, di(4-nonylphenyl)iodonium hexafluorophosphate, and 4-methylphenyl-4-(1-methylethyl)phenyliodonium tetrakis(pentafluorophenyl)borate.

12. The cationically curable resin composition according to claim 1 , wherein the component (A) comprises a hydrogenated bisphenol A epoxy resin in an amount of more than 80 mass % based on the entire component (A).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2018
From: MATSUOKA, HIROTO
To: THREEBOND CO., LTD.
Reel/Frame 047082/0416 →
Priority Claims (1)
JP 2016-076244 · Apr 6, 2016 · national
Continuity (1)
Related Publication 20190136041A1 · May 9, 2019
Cited By (1)
US 12,600,888